Haemonetics Total Long-Term Assets 2010-2024 | HAE

Haemonetics total long-term assets from 2010 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
Haemonetics Annual Total Long-Term Assets
(Millions of US $)
2024 $1,427
2023 $1,165
2022 $1,104
2021 $1,126
2020 $663
2019 $699
2018 $716
2017 $729
2016 $831
2015 $928
2014 $891
2013 $865
2012 $384
2011 $384
2010 $375
2009 $267
Haemonetics Quarterly Total Long-Term Assets
(Millions of US $)
2024-09-30 $1,569
2024-06-30 $1,562
2024-03-31 $1,427
2023-12-31 $1,435
2023-09-30 $1,146
2023-06-30 $1,161
2023-03-31 $1,165
2022-12-31 $1,172
2022-09-30 $1,149
2022-06-30 $1,133
2022-03-31 $1,104
2021-12-31 $1,102
2021-09-30 $1,102
2021-06-30 $1,110
2021-03-31 $1,126
2020-12-31 $650
2020-09-30 $658
2020-06-30 $674
2020-03-31 $663
2019-12-31 $655
2019-09-30 $623
2019-06-30 $644
2019-03-31 $699
2018-12-31 $712
2018-09-30 $713
2018-06-30 $690
2018-03-31 $716
2017-12-31 $722
2017-09-30 $718
2017-06-30 $723
2017-03-31 $729
2016-12-31 $810
2016-09-30 $822
2016-06-30 $828
2016-03-31 $831
2015-12-31 $835
2015-09-30 $918
2015-06-30 $919
2015-03-31 $928
2014-12-31 $924
2014-09-30 $918
2014-06-30 $907
2014-03-31 $891
2013-12-31 $885
2013-09-30 $892
2013-06-30 $888
2013-03-31 $865
2012-12-31 $875
2012-09-30 $878
2012-06-30 $388
2012-03-31 $384
2011-12-31 $381
2011-09-30 $383
2011-06-30 $385
2011-03-31 $384
2010-12-31 $377
2010-09-30 $376
2010-06-30 $374
2010-03-31 $375
2009-12-31 $308
2009-09-30 $308
2009-06-30 $296
2009-03-31 $267
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.851B $1.309B
Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $194.797B 24.85
Boston Scientific (BSX) United States $139.837B 40.20
Stryker (SYK) United States $139.395B 31.41
EssilorLuxottica (ESLOY) France $110.104B 0.00
Medtronic (MDT) Ireland $103.429B 15.36
Lonza Group Ag (LZAGY) Switzerland $43.664B 0.00
Haleon (HLN) United Kingdom $41.193B 26.76
GE HealthCare Technologies (GEHC) United States $38.725B 20.09
ResMed (RMD) United States $34.324B 28.21
Terumo (TRUMY) Japan $28.025B 39.58
Koninklijke Philips (PHG) Netherlands $24.269B 18.58
Zimmer Biomet Holdings (ZBH) United States $20.811B 13.25
Insulet (PODD) United States $19.068B 75.93
Baxter (BAX) United States $15.022B 9.77
Smith & Nephew SNATS (SNN) United Kingdom $10.471B 0.00
Bio-Rad Laboratories (BIO) United States $9.568B 32.52
BellRing Brands (BRBR) United States $9.145B 36.79
Demant (WILYY) Denmark $8.596B 0.00
Lantheus Holdings (LNTH) United States $6.666B 15.49
ICU Medical (ICUI) United States $3.779B 35.98
Prestige Consumer Healthcare (PBH) United States $3.656B 18.18
Perrigo (PRGO) Ireland $3.326B 9.79
Envista Holdings (NVST) United States $3.198B 23.82
QuidelOrtho (QDEL) United States $3.077B 19.81
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
Neogen (NEOG) United States $2.678B 30.90
GN Store Nord (GNNDY) Denmark $2.593B 16.63
LeMaitre Vascular (LMAT) United States $2.104B 51.14
Green Thumb Industries (GTBIF) United States $1.564B 27.37
AtriCure (ATRC) United States $1.531B 0.00
AdaptHealth (AHCO) United States $1.364B 9.75
InMode (INMD) Israel $1.335B 8.03
BioLife Solutions (BLFS) United States $1.234B 0.00
Maravai LifeSciences Holdings (MRVI) United States $1.225B 0.00
Owens & Minor (OMI) United States $1.071B 8.37
Curaleaf Holdings (CURLF) Canada $0.942B 0.00
Phibro Animal Health (PAHC) United States $0.812B 14.32
CeriBell (CBLL) United States $0.750B 0.00
Evolus (EOLS) United States $0.633B 0.00
Capricor Therapeutics (CAPR) United States $0.600B 0.00
VAREX IMAGING (VREX) United States $0.551B 24.31
Surmodics (SRDX) United States $0.549B 0.00
Omeros (OMER) United States $0.512B 0.00
Cresco Labs (CRLBF) United States $0.459B 0.00
Verano Holdings (VRNOF) United States $0.423B 0.00
ZimVie (ZIMV) United States $0.372B 31.37
Valneva SE (VALN) France $0.369B 0.00
Quanterix (QTRX) United States $0.363B 0.00
Viemed Healthcare (VMD) United States $0.310B 29.44
Biote (BTMD) United States $0.307B 6.73
Cerus (CERS) United States $0.293B 0.00
Sanara MedTech (SMTI) United States $0.282B 0.00
OraSure Technologies (OSUR) United States $0.270B 18.10
Canopy Growth (CGC) Canada $0.267B 0.00
High Tide (HITI) Canada $0.250B 103.00
Zynex (ZYXI) United States $0.249B 52.20
Aurora Cannabis (ACB) Canada $0.227B 0.00
Sanuwave Health (SNWV) United States $0.224B 3.15
Utah Medical Products (UTMD) United States $0.207B 14.26
MacroGenics (MGNX) United States $0.200B 0.00
Organigram Holdings (OGI) Canada $0.198B 0.00
Brainsway (BWAY) Israel $0.177B 94.00
TerrAscend (TSNDF) Canada $0.164B 0.00
TriSalus Life Sciences (TLSI) United States $0.157B 0.00
FitLife Brands (FTLF) United States $0.137B 17.21
Quipt Home Medical (QIPT) United States $0.129B 0.00
Jin Medical (ZJYL) China $0.126B 0.00
Veru (VERU) United States $0.114B 0.00
Fonar (FONR) United States $0.096B 10.88
Oramed Pharmaceuticals (ORMP) United States $0.096B 0.00
InterCure (INCR) Israel $0.076B 0.00
INLIF (INLF) $0.068B 0.00
Rockwell Medical (RMTI) United States $0.067B 34.67
Apyx Medical (APYX) United States $0.060B 0.00
Jushi Holdings (JUSHF) United States $0.059B 0.00
Exagen (XGN) United States $0.056B 0.00
Ayr Wellness (AYRWF) United States $0.052B 0.00
Cytosorbents (CTSO) United States $0.051B 0.00
ImmuCell (ICCC) United States $0.046B 0.00
Modular Medical (MODD) United States $0.046B 0.00
Safety Shot (SHOT) United States $0.037B 0.00
Nephros (NEPH) United States $0.016B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Innovative Eyewear (LUCY) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Allurion Technologies (ALUR) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Agape ATP (ATPC) $0.005B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Sharps Technology (STSS) United States $0.004B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 13.30
SNDL (SNDL) Canada $0.000B 0.00
Trinity Biotech (TRIB) Ireland $0.000B 0.00